Back to Journals » Patient Preference and Adherence » Volume 10

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?

Total article views   Abstract views HTML views PDF downloads Totals
12,065 Dovepress* 10,559 899+ 1,688 11,458
PubMed Central* 0 607 206 607
Totals 10,559 1,506 1,894 12,065
*Since 5 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar